NYU Study Validates Use Of The Fujirebio Diagnostics MESOMARK Test For Monitoring An Asbestos-Linked Cancer

Malvern, PA - There is new hope for the thousands of Americans suffering from mesothelioma, an aggressive form of cancer linked to asbestos exposure. Results from a recent study conducted by researchers at New York University (NYU) School of Medicine show the MESOMARK Assay, the world�s first and only in vitro test for monitoring mesothelioma developed by Fujirebio Diagnostics, Inc., is an effective way to measure proteins within the blood that reflect changes in disease. The findings represent a major milestone in the management of mesothelioma, as the test may enable doctors to more accurately monitor patients for treatment.

read>>>complete press release

The Mesothelioma Applied Research Foundation Calls for Passage of the Ban Asbestos in America Act of 2007

SANTA BARBARA, Calif., March 1 /PRNewswire/ -- The Mesothelioma Applied Research Foundation today applauds Senator Patty Murray for her steadfast leadership on behalf of the mesothelioma patient and research community and offers its endorsement of her legislation, "Ban Asbestos in America Act of 2007."


read>>>complete press release




Brayton Purcell supports passage of the Ban Asbestos Act of 2007

Beasley Allen Law Firm Supports Asbestos Ban

Inventor receives record $2.75m asbestos payout

By Brendan Roberts

February 06, 2007 12:00am

A MELBOURNE inventor who is dying from mesothelioma has settled with James Hardie and a second asbestos maker for a record $2.75 million payout.

Tim Lacone, 58, was developing a revolutionary swimming pool and industrial water filter when he was diagnosed with the debilitating and untreatable disease in August.

Dust from asbestos-based sheeting manufactured by the two companies in the 1970s, and used by Mr Lacone to build a glasshouse and his own rural home, had caused the onset of the disease, the Supreme Court heard.

Mr Lacone, who has just months to live, was six days into a civil trial with Amaca Pty Ltd (formerly James Hardie Pty Ltd) and Selstram Pty Ltd (formerly Wunderlich Pty Ltd) when the settlement was reached.

His solicitor, Margaret Kent, said she believed it was the biggest single asbestos-related payout in Australian history.


article

Mesothelioma Patient Will Mark Ten Years of Survival

This year, mesothelioma survivor Paul Kraus will mark the 10th year of his recovery from mesothelioma.

(PRWeb) February 1, 2007 -- This year, mesothelioma survivor Paul Kraus will mark the 10th year of his recovery from mesothelioma. In June 1997, Paul Kraus was diagnosed with mesothelioma and given only a few months to live. He and his family were stunned by the shocking diagnosis, but were not ready to give up. They researched different therapies for this cancer and learned about various conventional, integrative and alternative treatments. From this knowledge, Mr. Kraus created his own path to heal his mesothelioma.

press release

Welcome to the Mesothelioma Report.


This is a news and information site for malignant mesothelioma, a disease in which cancer cells form in the lining of the chest or abdomen